Cellectis to receive European patent for CRISPR use in T-cellspharmabiz.comCellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), has announced the grant by the European Pat… Continue reading
|
Health Shorts: Stem cell ‘cures,’ Sugar spike, Longevity
Gainesville Sun Stem cell clinics offering unapproved treatments for ailments from hip pains to erectile dysfunction increasingly use a federal clinical-trials database as a marketing tool — a strategy that confuses patients and exposes them to “unjustifiable” safety … |
|
Research offers explanation for ineffectiveness of checkpoint immunotherapy against bladder cancer
News-Medical.net New research offers a possible explanation for why a new type of cancer treatment hasn’t been working as expected against bladder cancer. The study finds that checkpoint immunotherapy, which is designed to activate the immune system, is not effective … |
|
Stem cell company for sports legends facing financial complaints
USA TODAY SAN DIEGO – The company that manufactured experimental stem cell medicine for several aging sports heroes is facing several complaints in court for large unpaid bills, as well as a complaint by an investor who accuses the company of misusing funds and … |
USA TODAY |
Stem cell company for sports legends facing financial complaints
USA TODAY SAN DIEGO – The company that manufactured experimental stem cell medicine for several aging sports heroes is facing several complaints in court for large unpaid bills, as well as a complaint by an investor who accuses the company of misusing funds and … |